Cardiovascular Risk in Acromegaly
References
- Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008; 93:61–67.
- Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab. 2004; 89:667–674.
- Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A. A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018; 14:552–561.
- Bolanowski M, Ruchała M, Zgliczyński W, Kos-Kudła B, Bałdys-Waligórska A, Zieliński G, Bednarczuk T, Hubalewska-Dydejczyk A, Kamiński G, Marek B, Daroszewski J, Waśko R, Lewiński A. Akromegalia - nowe spojrzenie na pacjenta. Polskie propozycje postępowania diagnostyczno-terapeutycznego w akromegalii w świetle aktualnych doniesień Endokrynologia Polska. 2014; 65:326–331.
- Lie JT. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J. 1980; 100:41-52.
- Frustaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F, Leri A, Kajstura J, Anversa P, Maseri A. Cell death in acromegalic cardiomyopathy. Circulation. 1999; 99:1426-1434
- Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996; 335:1182–1189.
- Sabbah HN, Sharov VG. Apoptosis in heart failure. Prog Cardiovasc Dis. 1998; 40:549-562.
- Bihan H, Espinosa C, Valdes-Socin H, Salenave S, Young J, Levasseur S, Assayag P, Beckers A, Chanson P. Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab. 2004; 89:5308–5313.
- Casini AF, Neto LV, Fontes R, França RF, Xavier SS, Gadelha MR. Aortic root ectasia in patients with acromegaly: experience at a single center. Clin Endocrinol (Oxf). 2011; 75:495–500.
- Saccà L, Napoli R, Cittadini A. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol (Oxf). 2003; 59:660–671.
- Colao A, Spinelli L, Marzullo P, Pivonello R, Petretta M, Di Somma C, Vitale G, Bonaduce D, Lombardi G. High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. J Clin Endocrinol Metab. 2003; 88:3196-201.
- de Jong S, van Veen TAB, van Rijen HVM, de Bakker JMT. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol. 2011; 57:630-638.
- Seale WL, Gang ES, Peter CT. The use of signal-averaged electrocardiography in predicting patients at high risk for sudden death. Pacing Clin Electrophysiol. 1990; 13:796-807.
- Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly. Eur Heart J. 1992; 13:51-56.
- Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB. Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J. 1989; 62:185–194.
- Vitale G, Pivonello R, Auriemma RS, Guerra E, Milone F, Savastano S, Lombardi G, Colao A. Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin Endocrinol (Oxf). 2005; 63:470–476.
- Ikkos D, Luft R, Sjögren B. Body water and sodium in patients with acromegaly 1. J Clin Invest. 1954; 33:989–994.
- Møller J, Nielsen S, Hansen TK. Growth hormone and fluid retention. Horm Res. 1999; 51(Suppl 3):116–120.
- Kamenický P, Mazziotti G, Lombès M, Giustina A, Chanson P. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev. 2014; 35:234-281.
- Deray G, Chanson P, Maistre G, Warnet A, Eurin J, Barthelemy C, Masson F, Martinez F, Lubetzki J, Legrand JC. Atrial natriuretic factor in patients with acromegaly. Eur J Clin Pharmacol. 1990; 38:409–413.
- Møller J, Jørgensen JO, Marqversen J, Frandsen E, Christiansen JS. Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor. Clin Endocrinol (Oxf). 2000; 52:181-186.
- Karlberg BE, Ottosson A-M. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol. 1982; 100:581-587.
- Clemmons DR. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary. 2002; 5:181-183.
- Colao A, Ferone D, Marzullo P, Lombardi G. Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. Endocrine Reviews. 2004; 25:102–52.
- Weiss V, Sonka K, Pretl M, Dostálová S, Klozar J, Rambousek P, Marek J, Haas T. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest. 2000; 23:515-519.
- Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017; 20:46-62.
- Nishijima T, Tajima K, Yamashiro Y, Hosokawa K, Suwabe A, Takahashi K, et al. Elevated Plasma Levels of Soluble (Pro)Renin Receptor in Patients with Obstructive Sleep Apnea Syndrome in Parallel with the Disease Severity. Tohoku J Exp Med. 2016; 238:325-38.
- Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003; 16:274-80.
- Khayat RN, Varadharaj S, Porter K, Sow A, Jarjoura D, Gavrilin MA, et al. Angiotensin Receptor Expression and Vascular Endothelial Dysfunction in Obstructive Sleep Apnea. Am J Hypertens. 2018; 31:355-61.
- Tsioufis C, Dimitriadis K, Katsiki N, Tousoulis D. Microcirculation in Hypertension: An Update on Clinical Significance and Therapy. Curr Vasc Pharmacol. 2015; 13:413-417.
- Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015; 116:1007-1021.
- Annamalai AK, Webb A, Kandasamy N, Elkhawad M, Moir S, Khan F, Maki-Petaja K, Gayton EL, Strey CH, O'Toole S, Ariyaratnam S, Halsall DJ, Chaudhry AN, Berman L, Scoffings DJ, Antoun NM, Dutka DP, Wilkinson IB, Shneerson JM, Pickard JD, Simpson HL, Gurnell M. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab. 2013; 98:1040-1050.
- Sardella C, Urbani C, Lombardi M, Nuzzo A, Manetti L, Lupi I, Rossi G, Del Sarto S, Scattina I, Di Bello V, Martino E, Bogazzi F. The beneficial effect of acromegaly control on blood pressure values in normotensive patients. Clin Endocrinol (Oxf). 2014; 81:573-581.
- Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G, Cassone R. Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol (Oxf). 2001; 55:307-313.
- Katznelson L, Laws ER, Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society Acromegaly: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2014; 99:3933-3951.
Language: English
Page range: 43 - 55
Published on: Apr 15, 2023
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2023 Mariana Dobrescu, Diana Păun, Adina Ghimigean, Sorina Buculei, Cătălina Poiană, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.